SLDXSTELLA DIAGNOSTICS INC.

About STELLA DIAGNOSTICS INC. (SLDX)

STELLA DIAGNOSTICS INC. (SLDX) is a Diagnostics & Research company headquartered in Salt Lake City, UT, United States whose shares trade over-the-counter on the Pink tier.

Stella Diagnostics, Inc. through one of its subsidiaries, World Reach Pharma, LLC will harness the power of biotechnology, innovation, and science to deliver high-quality CGMP pharmaceutical products to patients and healthcare providers. As an innovative 503B Outsourcing Facility, we will be a premier provider of superior compounded medications that protect, improve, and enhance patients' lives - all at affordable prices. Obtaining a 503B designation will allow us to produce sterile and non-sterile medications in bulk under strict FDA oversight, ensuring the highest safety and quality standards. WRP will special in addressing drug shortages, customizing formulations to meet specific healthcare needs, and delivering scalable solutions for healthcare facilities. By leveraging advanced manufacturing technologies and streamlined processes, WRP will develop a customized product portfolio with vastly reduced development times and costs. This will enables us to quickly respond to market demands and provide tailored solutions that will empower healthcare providers to deliver exceptional care.

Products and services

World Reach Pharma, LLC ("WRP") will harness the power of biotechnology, innovation, and science to deliver high-quality CGMP pharmaceutical products to patients and healthcare providers. As an innovative 503B Outsourcing Facility, we will be a premier provider of superior compounded medications that protect, improve, and enhance patients' lives—all at affordable prices. Obtaining a 503B designation will allow us to produce sterile and non-sterile medications in bulk under strict FDA oversight, ensuring the highest safety and quality standards. WRP will special in addressing drug shortages, customizing formulations to meet specific healthcare needs, and delivering scalable solutions for healthcare facilities. By leveraging advanced manufacturing technologies and streamlined processes, WRP will develop a customized product portfolio with vastly reduced development times and costs. This will enables us to quickly respond to market demands and provide tailored solutions that will empower healthcare providers to deliver exceptional care.

SLDX key facts

Ticker symbol

SLDX

Market tier

Pink

Sector

Healthcare

Industry

Diagnostics & Research

Headquarters

Salt Lake City, UT, United States

Country of incorporation

US

Year of incorporation

2014

Employees

3

Estimated market cap

$18.00M (as of May 14, 2025)

Shares outstanding

367,361,868

Reporting standard

Alternative Reporting Standard

Audit status

Unaudited

Fiscal year end

12/31

Latest filing

Annual Report (Dec 31, 2024)

STELLA DIAGNOSTICS INC. leadership

• David Seaburg — CEO, Principal Executive Officer, Principal Fin. Officer

Explore more: Diagnostics & Research stocks · Healthcare sector · Pink stocks · OTC stocks starting with S